Skip to main content

Day: September 16, 2025

Strata Acquires Keystone Perfusion, Creating Integrated Organ Recovery Platform, Diversifying into Other Medical Services

Keystone is expected to generate approximately $65 million of revenue and approximately $13 million of Adjusted EBITDA(1) in the full-year 2025, with revenue expected to grow more than 50% in 2025 versus 2024 Acquisition follows multi-year partnership between Strata and Keystone whereby Keystone has successfully recovered hundreds of organs on behalf of Strata customers $124 million acquisition represents an approximate 9x multiple of 2025 estimated Adjusted EBITDA(1); Keystone’s go forward Free Cash Flow(1) conversion is expected to be approximately 80%NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) — Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE), today announced that it has completed the acquisition of Keystone Perfusion...

Continue reading

Bitcoin Bancorp Secures NASDAQ Ticker Reservation “BCBC” as Part of Uplisting Strategy

LAS VEGAS, Sept. 16, 2025 (GLOBE NEWSWIRE) — Bitcoin Bancorp. (OTC: BULT) (“Bitcoin Bancorp” or the “Company”), formerly Bullet Blockchain, Inc., today announced that the NASDAQ has confirmed the reservation of the ticker symbol “BCBC” for the Company. This development represents a significant milestone in Bitcoin Bancorp’s ongoing strategy to pursue an uplisting to NASDAQ. In its confirmation letter, NASDAQ stated: “Your request to reserve the ticker symbol ‘BCBC’ for Bullet Blockchain Inc. has been approved and will be reserved for you for twenty-four months from the date of the reservation, July 29, 2027. Nasdaq is committed to supporting our global network of companies throughout all their life stages—before, during and after the Listing.” The reservation of “BCBC” strengthens the Company’s positioning as it advances its transition...

Continue reading

SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics

West Conshohocken, PA, Sept. 16, 2025 (GLOBE NEWSWIRE) — SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company focused on rare diseases and medical emergencies, today announced the successful completion of its acquisition of Y-mAbs Therapeutics, Inc. (“Y-mAbs”), a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the treatment of cancer.  “We are excited to welcome Y-mAbs into SERB. The acquisition strengthens our Rare Oncology portfolio with the addition of Danyelza® (naxitamab-gqgk) and brings deep oncology expertise that will help us to expand our partnerships with the US oncology community and to advance treatments for rare and hard-to-treat cancers”, said Vanessa Wolfeler, Chief Executive Officer of SERB. “This marks a significant...

Continue reading

AvePoint Announces Pricing of Public Offering

JERSEY CITY, N.J., Sept. 16, 2025 (GLOBE NEWSWIRE) — AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced the pricing of an underwritten public offering (the “Offering”) of 13,290,360 shares of its common stock, par value $0.0001, with such shares of common stock being offered by the selling stockholders named in the prospectus (the “Selling Stockholders”), at a public offering price of S$19.50 per share, in connection with the previously announced plan to list its shares of common stock on the Main Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”). AvePoint’s common stock is listed on Nasdaq under the symbol “AVPT.” AvePoint’s common stock is expected to begin trading on the SGX-ST at 9:00 a.m. (Singapore time) on September 19, 2025 under the symbol “AVP”,...

Continue reading

Miata Metals Hits Gold in Two Additional Targets with 5.3 m at 6.57 g/t Gold at Puma and 14m at 1.72 g/t Gold at Golden Hand

VANCOUVER, British Columbia, Sept. 16, 2025 (GLOBE NEWSWIRE) — Miata Metals Corp. (CSE: MMET) (FSE: 8NQ) (OTCQB: MMETF) (“Miata” or the “Company”) is pleased to announce significant drill results from two different targets at its Sela Creek Gold Project (“Sela Creek” or the “Project”) in Suriname. Results include near-surface, high-grade mineralization in hard rock at the Puma Target (“Puma”) and wide mineralized intervals at depth at the Golden Hand Target (“Golden Hand”), further demonstrating the district-scale potential of Sela Creek. HighlightsDrilling at the Puma Target yielded another shallow high-grade intercept in 25DDH-SEL-030 of 5.3m at 6.57 g/t gold from 37.3m1 in hard rock, including2.5 m at 13.10 g/t gold from 37.7m, and 0.5 m at 51.16 g/t gold from 39.7m.The intercept projects to a surface adit approximately...

Continue reading

Worthington Enterprises Releases 2025 Corporate Citizenship and Sustainability Report

COLUMBUS, Ohio, Sept. 16, 2025 (GLOBE NEWSWIRE) — Worthington Enterprises Inc. (NYSE: WOR), a designer and manufacturer of market-leading brands that help improve everyday life by elevating spaces and experiences, today published its annual Corporate Citizenship and Sustainability Report detailing the Company’s commitments, management approach and achievements within the categories of People, Planet, Products and Governance. Through the lens of sustainability, Worthington Enterprises aspires to achieve a balance of people, planet and prosperity to meet the needs of today without compromising tomorrow. Some of the notable accomplishments during fiscal 2025 included:Prioritizing safety as demonstrated by outperforming the industry’s average safety total case incident rate by 40%. To accelerate progress toward zero recordable injuries...

Continue reading

HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development

Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the treatment of solid tumors Discovery of unique combination of cytokines in multi-functional fusion protein molecule that exhibits ability to expand TPEX cells without cytokine storm in preclinical studies Definitive data from preclinical studies shared at Scientific Seminar Series held at Nova Southeastern University on September 12, 2025, in Fort Lauderdale, Florida MIRAMAR, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, announced data highlights...

Continue reading

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Generates Additional Yield for 100,000 HYPE Currently Staked by the Company LAGUNA HILLS, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) — Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE, today announced its first HYPE Asset Use Service (“HAUS”) agreement with proprietary trading firm Credo Cayman (“Credo”). Through this first-of-its-kind on-chain service, Hyperion DeFi provides the use of 100,000 staked HYPE to Credo, enabling the firm to substantially reduce transaction fees when trading on Hyperliquid. The resulting net fee savings will be shared between the two companies, creating a new revenue stream for both. “Hyperion DeFi’s launch of HAUS Credo further demonstrates the Company’s ability to access...

Continue reading

Duos Deploys 5th Edge Data Center

Dumas, located in the Texas Panhandle, becomes the latest Duos Edge data center to be deployed JACKSONVILLE, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) — Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, versatile and streamlined Edge Data Center (“EDC”) solutions tailored to meet evolving needs in any environment, today announced its latest data center deployment towards its anticipated goal of 15 deployments by year end. The latest EDC is in partnership with Dumas Independent School District (“Dumas ISD”) to deploy an on premise EDC in Dumas, Texas. This project marks another milestone in Duos Edge AI’s expansion into rural communities, providing low-latency compute and connectivity that directly support K-12 education...

Continue reading

Aqua Metals and Impossible Metals Sign MOU to Advance Sustainable U.S. Critical Minerals Supply Chain

Partnership Would Combine Responsible Seabed Mining and Domestic Refining to Strengthen America’s Critical Mineral Independence RENO, Nev., Sept. 16, 2025 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals”), a leader in clean metals recycling, announced today it has entered into a Memorandum of Understanding (MOU) with Impossible Metals, Inc. (“Impossible Metals”), a pioneer in selective seabed mineral collection. The two companies will work together to evaluate a new pathway for producing and refining the minerals most vital to electrification, national defense, and clean energy technologies. By pairing Impossible Metals’ innovative approach to responsibly harvesting polymetallic nodules from the deep-sea floor with Aqua Metals’ proprietary AquaRefining™ platform, the collaboration seeks to establish a fully...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.